OI
37
-6
WM
74
-2
USB
46
-2
GE
57
-5
V
48
-6
TGNA
66
-3
GOOG
42
-11
BA
39
-5
PCG
58
-3
CMG
47
-3
GRMN
43
-2
DUK
62
3
MDLZ
67
-2
LEN
11
-3
ADI
47
-4
EQIX
50
-3
ADT
66
-5
ALLE
35
-6
MO
69
-2
CSCO
58
-2
OI
37
-6
WM
74
-2
USB
46
-2
GE
57
-5
V
48
-6
TGNA
66
-3
GOOG
42
-11
BA
39
-5
PCG
58
-3
CMG
47
-3
GRMN
43
-2
DUK
62
3
MDLZ
67
-2
LEN
11
-3
ADI
47
-4
EQIX
50
-3
ADT
66
-5
ALLE
35
-6
MO
69
-2
CSCO
58
-2
Financhill
Back

ProQR Therapeutics NV 10K Form

Sell
6

PRQR
ProQR Therapeutics NV

Last Price:
$1.34
Seasonality Move:
1.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRQR News And Ratings

See the #1 stock for the next 7 days that we like better than PRQR

PRQR Financial Statistics

Sales & Book Value

Annual Sales: $20.5M
Cash Flow: $-9.8M
Price / Cash Flow: 0
Annual Sales: $0.88
Price / Book: 1.6

Profitability

EPS (TTM): -0.33600
Net Income (TTM): $-30.1M
Gross Margin: $0
Return on Equity: -62.97%
Return on Assets: -21.26%

ProQR Therapeutics NV Earnings Forecast

Key ProQR Therapeutics NV Financial Ratios

  • The Selling, General & Administrative Expenses for PRQR have been equal to 72.26% of Gross Profit Margin.
  • The Research & Development expenses have been 192.31% of Revenue.
  • The Net Earning history of PRQR is -146.86% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

ProQR Therapeutics NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PRQR
CUSIP: N71542
Website: proqr.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 3.95
Quick Ratio: 3.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRQR Technical Analysis vs Fundamental Analysis

Sell
6
ProQR Therapeutics NV (PRQR) is a Sell

Is ProQR Therapeutics NV a Buy or a Sell?